ArticleCancer discovery2013

Two is better than one: combining IGF1R and MEK blockade as a promising novel treatment strategy against KRAS-mutant lung cancer.

Ron Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.